Related Experiment Video
Updated: Jul 28, 2026

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology
Published on: August 18, 2014
Beta adrenoreceptors in the rabbit bladder detrusor muscle
Rabbit detrusor smooth muscle primarily contains beta-2 adrenergic receptors, with a minor population of beta-1 adrenergic receptors also identified. This research clarifies receptor subtypes in this crucial tissue.
Area of Science:
- Pharmacology
- Physiology
- Molecular Biology
Background:
- Beta adrenergic receptors play a critical role in regulating smooth muscle function.
- Understanding the specific subtypes of beta adrenergic receptors in the detrusor smooth muscle is essential for targeted pharmacological interventions.
Purpose of the Study:
- To characterize the subtypes of beta adrenergic receptors present in rabbit detrusor smooth muscle.
- To quantify the relative proportions of beta-1 and beta-2 adrenergic receptor subtypes.
Main Methods:
- Radioligand binding assays using [125I]iodocyanopindolol (ICYP) on isolated rabbit detrusor smooth muscle membranes.
- Saturation binding experiments to determine receptor affinity (KD) and density (Bmax).
- Displacement studies with a panel of beta adrenergic agents to identify receptor subtypes and affinities.
Main Results:
- Saturation binding revealed a KD for ICYP of 14.7 pM and a maximum binding of 147.6 fmol/mg protein.
- Displacement studies indicated a predominant population of beta-2 adrenergic receptors, with affinities for I-propranolol (0.76 nM) and ICI 118,551 (1.7 nM) being significantly lower than for zinterol (38.0 nM), metoprolol (3.5 microM), and practolol (61.4 microM).
- Hofstee plot analysis suggested the presence of a minor population of beta-1 adrenergic receptors, estimated to constitute approximately 13-23% of the total beta adrenergic receptor population.
Conclusions:
- The rabbit detrusor smooth muscle predominantly expresses beta-2 adrenergic receptors.
- A heterogeneous receptor population exists, with a small but significant presence of beta-1 adrenergic receptors.
- These findings have implications for understanding detrusor muscle physiology and developing targeted therapies.
More Related Videos
08:30Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents
Published on: January 31, 2020
06:36A Decentralized (Ex Vivo) Murine Bladder Model with the Detrusor Muscle Removed for Direct Access to the Suburothelium during Bladder Filling
Published on: November 28, 2019
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Action of β1 Blockers